HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 95 filers reported holding HARROW HEALTH INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,325 | +31.0% | 20,134 | +73.6% | 0.00% | – |
| Q2 2023 | $220,807 | -69.9% | 11,597 | -66.6% | 0.00% | – |
| Q1 2023 | $734,569 | +387.0% | 34,715 | +239.7% | 0.00% | – |
| Q4 2022 | $150,832 | +1575.9% | 10,219 | +1333.2% | 0.00% | – |
| Q3 2022 | $9,000 | -75.7% | 713 | -85.6% | 0.00% | – |
| Q2 2022 | $37,000 | +8.8% | 4,968 | +0.0% | 0.00% | – |
| Q1 2022 | $34,000 | -12.8% | 4,967 | +11.3% | 0.00% | – |
| Q4 2021 | $39,000 | +457.1% | 4,463 | +466.4% | 0.00% | – |
| Q3 2021 | $7,000 | -76.7% | 788 | -75.2% | 0.00% | – |
| Q2 2021 | $30,000 | -77.6% | 3,178 | -84.0% | 0.00% | – |
| Q1 2021 | $134,000 | +97.1% | 19,811 | +101.6% | 0.00% | – |
| Q4 2020 | $68,000 | +106.1% | 9,828 | +67.9% | 0.00% | – |
| Q3 2020 | $33,000 | -84.1% | 5,852 | -85.3% | 0.00% | – |
| Q2 2020 | $208,000 | +100.0% | 39,912 | +47.0% | 0.00% | – |
| Q1 2020 | $104,000 | +420.0% | 27,152 | +573.1% | 0.00% | – |
| Q1 2019 | $20,000 | – | 4,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
| Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
| Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
| Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
| Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
| Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
| Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
| CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
| BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |